Elliot Shin
Family Medicine · Las Vegas, NVNPI 1275554057
Payments from drug & device makers
Across 1,126 payments — averaging $1870.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim International GmbH$501K
- Incyte Corporation$304K
- Braintree Laboratories, Inc.$169K
- Amgen$147K
- Sanofi US Services Inc.$138K
- Alnylam Pharmaceuticals Inc.$137K
- plus $710K from 17 others
Across 25 payments — averaging $220.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$3K
- Sanofi US Services Inc.$2K
- Gilead$1K
What the payments were for
- Travel & lodging$8,37977%
- Food & beverage$2,54223%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim International GmbH | 353 | $500,886 |
| Incyte Corporation | 102 | $304,458 |
| Braintree Laboratories, Inc. | 29 | $168,941 |
| Amgen | 8 | $147,199 |
| Sanofi US Services Inc. | 20 | $138,221 |
| Alnylam Pharmaceuticals Inc. | 2 | $136,703 |
| AbbVie | 76 | $119,189 |
| Novo Nordisk AS | 379 | $105,636 |
| GSK | 27 | $82,261 |
| Galderma Laboratories, L.p. | 12 | $73,458 |
| Biogen | 15 | $66,854 |
| Lexicon Pharmaceuticals, Inc. | 17 | $60,038 |
| E.r. Squibb & Sons, L.L.C. | 2 | $57,194 |
| Organon | 16 | $49,551 |
| Chiesi USA, Inc. | 20 | $45,584 |
| Merck | 39 | $19,179 |
| Eli Lilly | 3 | $11,434 |
| Astrazeneca UK Limited | 1 | $9,100 |
| Bayer | 1 | $7,250 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $2,000 |
| Pfizer | 1 | $728 |
| Si-bone, Inc. | 1 | $128 |
| Novo Nordisk | 1 | $92 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- iFuse Implant$128
How this compares
$2,106,085 in reported general payments places this provider in the 95th percentile of 902 family medicine providers in Nevada.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humalog Kwikpen U-200Insulin Lispro | 11 | $5,635 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 11 | $1,130 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Las Vegas
- Rogelio MachucaLas Vegas$3.3M
- Maxine InghamLas Vegas$2.9M
- Robert KaplanLas Vegas$1.7M
- Sean SuLas Vegas$1.1M
- Naz WahabLas Vegas$735K
- Carmelo RilleraLas Vegas$531K
- Peter PhilanderLas Vegas$524K
- Jerry CadeLas Vegas$381K
- Dana ForteLas Vegas$169K
- Francisco MachucaLas Vegas$96K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.